Literature DB >> 11462217

Does neuronal loss in Parkinson's disease involve programmed cell death?

J K Andersen1.   

Abstract

Recently it has been hypothesized that apoptotic cell death is involved in several neuropathological conditions including Parkinson's disease (PD). Initial morphological studies assessing the presence of apoptosis in Parkinsonian brain tissues yielded mixed results. Based on more recent studies in human PD brains as well in animal and cell culture models of the disease, a picture is emerging, however, that strongly suggests that many of the molecular players thought to participate in this type of neuronal cell death are active in the disease. The task of researchers in the field is now to deduce how these players may be interacting with one another to bring about cell death in PD and to design effective therapies to interfere with these processes. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462217     DOI: 10.1002/bies.1089

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  15 in total

1.  Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Authors:  V Viswanath; Y Wu; R Boonplueang; S Chen; F F Stevenson; F Yantiri; L Yang; M F Beal; J K Andersen
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability.

Authors:  M Saldaña; E Aguilar; M Bonastre; C Marin
Journal:  J Neural Transm (Vienna)       Date:  2007-07-04       Impact factor: 3.575

3.  Let-7d microRNA Attenuates 6-OHDA-Induced Injury by Targeting Caspase-3 in MN9D Cells.

Authors:  Li Li; Hui Liu; Haijing Song; Yingsong Qin; Ying Wang; Ming Xu; Chaoxia Liu; Jin Gao; Shen Sun
Journal:  J Mol Neurosci       Date:  2017-10-29       Impact factor: 3.444

Review 4.  Melatonin and Parkinson's disease.

Authors:  Juan C Mayo; Rosa M Sainz; Dun-Xian Tan; Isaac Antolín; Carmen Rodríguez; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

5.  The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss.

Authors:  Elizabeth M Kline; Laura M Butkovich; Joshua M Bradner; Jianjun Chang; Harris Gelbard; Val Goodfellow; W Michael Caudle; Malú G Tansey
Journal:  Exp Neurol       Date:  2019-05-08       Impact factor: 5.330

6.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

7.  Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.

Authors:  C J Barnum; K L Eskow; K Dupre; P Blandino; T Deak; C Bishop
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 8.  En1 and Wnt signaling in midbrain dopaminergic neuronal development.

Authors:  Maria T M Alves dos Santos; Marten P Smidt
Journal:  Neural Dev       Date:  2011-05-10       Impact factor: 3.842

9.  DHA Hydroperoxides as a Potential Inducer of Neuronal Cell Death: a Mitochondrial Dysfunction-Mediated Pathway.

Authors:  Xuebo Liu; Takahiro Shibata; Shinsuke Hisaka; Yoshichika Kawai; Toshihiko Osawa
Journal:  J Clin Biochem Nutr       Date:  2008-07       Impact factor: 3.114

10.  Treadmill exercise alleviates short-term memory impairment in 6-hydroxydopamine-induced Parkinson's rats.

Authors:  Han-Sam Cho; Mal-Soon Shin; Wook Song; Tae-Won Jun; Baek-Vin Lim; Young-Pyo Kim; Chang-Ju Kim
Journal:  J Exerc Rehabil       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.